Drug Type Universal CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism CLL-1 modulators(C-Type lectin domain family 12 member A modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory acute myeloid leukemia | Phase 1 | China | 02 Mar 2026 | |
| Relapsing acute myeloid leukemia | Phase 1 | China | 02 Mar 2026 | |
| Acute Myeloid Leukemia | Preclinical | China | 19 Nov 2025 |





